Adjuvant therapy with 1% alendronate gel for experimental periodontitis treatment in rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to evaluate the effects of locally delivered 1% alendronate (ALN) gel used as an adjunct to non-invasive periodontal therapy. Methods: Ligature-induced periodontitis was performed in 96 rats. The ligature was tied in the cervical area of the mandibular left first molar. The animals were randomly divided into 4 groups: 1) NT, no treatment; 2) SRP, scaling and root planning; 3) SRP/PLA, SRP followed by filling the periodontal pocket with placebo gel (PLA); and 4) SRP/ALN, SRP followed by filling the periodontal pockets with 1% ALN gel. Histomorphometric (percentage of bone in the furcation region [PBF]) and immunohistochemical (receptor activator of nuclear factor-κB ligand, osteoprotegerin, and tartrate-resistant acid phosphatase) analyses were performed. Data were statistically analyzed, with the threshold of statistical significance set at P≤0.05. Results: The SRP, SRP/PLA, and SRP/ALN groups presented a higher PBF than the NT group (P≤0.01) at 7, 15, and 30 days. The SRP/ALN group presented a higher PBF than the SRP/PLA group in all experimental periods, as well as a higher PBF than the SRP group at 15 and 30 days. No differences were observed in the immunohistochemical analyses (P>0.05 for all). Conclusions: Locally delivered 1% ALN gel used as an adjunct to SRP enhanced bone regeneration in the furcation region in a rat model of experimental periodontitis.
Abstract
Purpose: The aim of this study was to evaluate the effects of locally delivered 1% alendronate (ALN) gel used as an adjunct to non-invasive periodontal therapy. Methods: Ligature-induced periodontitis was performed in 96 rats. The ligature was tied in the cervical area of the mandibular left first molar. The animals were randomly divided into 4 groups: 1) NT, no treatment; 2) SRP, scaling and root planning; 3) SRP/PLA, SRP followed by filling the periodontal pocket with placebo gel (PLA); and 4) SRP/ALN, SRP followed by filling the periodontal pockets with 1% ALN gel. Histomorphometric (percentage of bone in the furcation region [PBF]) and immunohistochemical (receptor activator of nuclear factor-κB ligand, osteoprotegerin, and tartrate-resistant acid phosphatase) analyses were performed. Data were statistically analyzed, with the threshold of statistical significance set at P≤0.05. Results: The SRP, SRP/PLA, and SRP/ALN groups presented a higher PBF than the NT group (P≤0.01) at 7, 15, and 30 days. The SRP/ALN group presented a higher PBF than the SRP/PLA group in all experimental periods, as well as a higher PBF than the SRP group at 15 and 30 days. No differences were observed in the immunohistochemical analyses (P>0.05 for all). Conclusions: Locally delivered 1% ALN gel used as an adjunct to SRP enhanced bone regeneration in the furcation region in a rat model of experimental periodontitis.
참고문헌 (40)
- Bartold PM, "Host modulation : controlling the inflammation to control the infection", Periodontol 2000, 75, pp.317~329 (2017)
- Jepsen K, "Antibiotics", antimicrobials : systemic and local administration in the therapy of mild to moderately advanced periodontitis, 2016, pp.71, 82~112
- Akram Z, "Effect of photodynamic therapy and laser alone as adjunct to scaling and root planing on gingival crevicular fluid inflammatory proteins in periodontal disease : A systematic review", Photodiagnosis Photodyn Ther, 16, pp.142~153 (2016)
- Lane N, "Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebocontrolled study", J Periodontol, 76, pp.1113~1122 (2005)
- Pradeep AR, "1% alendronate gel as local drug delivery in the treatment of Class II furcation defects : a randomized controlled clinical trial", J Periodontol, 84, pp.307~315 (2013)
- Nakagawa T, "Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2", Arch Oral Biol, 60, pp.557~565 (2015)
- Reszka AA, "Mechanism of action of bisphosphonates", Curr Osteoporos Rep, 1, pp.45~52 (2003)
- Teronen O, "Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate", J Dent Res, 76, pp.1529~1537 (1997)
- Giannobile WV, "Host-response therapeutics for periodontal diseases", J Periodontol, 79, pp.1592~1600 (2008)
- Sharma A, "Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial", J Periodontol, 83, pp.11~18 (2012)
- Weinreb M, "Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys", J Periodontal Res, 29, pp.35~40 (1994)
- Malden N, "An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence", J Bone Miner Metab, 30, pp.171~182 (2012)
- Pradeep AR, "Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus : a double-masked controlled clinical trial", J Periodontol, 83, pp.1322~1328 (2012)
- Sharma A, "Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers", J Appl Oral Sci, 25, pp.243~249 (2017)
- Dutra BC, "Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects : a 6-month clinical trial", J Appl Oral Sci, 25, pp.310~317 (2017)
- Sharma A, "Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis : a randomized controlled clinical trial", J Periodontol, 83, pp.19~26 (2012)
- Wanikar I, "Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects", J Periodontol, 90, pp.52~60 (2019)
- Kanoriya D, "Mandibular degree II furcation defects treatment with platelet-rich fibrin and 1% alendronate gel combination : a randomized controlled clinical trial", J Periodontol, 88, pp.250~258 (2017)
- Fernandes LA, "Experimental periodontal disease treatment by subgingival irrigation with tetracycline hydrochloride in rats", J Appl Oral Sci, 18, pp.635~640 (2010)
- Nunes NL, "Effects of local administration of tiludronic acid on experimental periodontitis in diabetic rats", J Periodontol, 89, pp.105~116 (2018)
- Garcia VG, "Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil", Support Care Cancer, 23, pp.2007~2017 (2015)
- Garcia VG, "Effect of the concentration of phenothiazine photosensitizers in antimicrobial photodynamic therapy on bone loss and the immune inflammatory response of induced periodontitis in rats", J Periodontal Res, 49, pp.584~594 (2014)
- Oz HS, "Animal models for periodontal disease", J Biomed Biotechnol, 2011, pp.754857~ (2011)
- Sanz M, "Innovations in non-surgical periodontal therapy: consensus report of the Sixth European Workshop on Periodontology", J Clin Periodontol, 35, pp.3~7 (2008)
- Reddy GT, "Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis", Drug Deliv, 12, pp.217~222 (2005)
- Akram Z, "Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease : a systematic review", Br J Clin Pharmacol, 83, pp.444~454 (2017)
- Baron R, "Denosumab and bisphosphonates : different mechanisms of action and effects", Bone, 48, pp.677~692 (2011)
- Halasy-Nagy JM, "Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis", Bone, 29, pp.553~559 (2001)
- Kuroshima S, "Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice", Endocrinology, 153, pp.17~28 (2012)
- Nagata MJ, "Long-term therapy with intravenous zoledronate increases the number of nonattached osteoclasts", J Craniomaxillofac Surg, 45, pp.1860~1867 (2017)
- Kaynak D, "A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats", J Periodontol, 71, pp.790~796 (2000)
- Gong X, "Skeletal site-specific effects of zoledronate on in vivo bone remodeling and in vitro BMSCs osteogenic activity", Sci Rep, 7, pp.36129~ (2017)
- Dobnig H, "Changes in the RANK ligand", osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonatetreated osteoporotic patients, 2006, pp.17, 693~703
- De Almeida J, "Adjuvant therapy with sodium alendronate for the treatment of experimental periodontitis in rats", J Periodontol, 86, pp.1166~1175 (2015)
- YongHeeKim, "Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression", Experimental and Molecular Medicine, 34(2), pp.8~151 (2002), 생화학분자생물학회
- Brunsvold MA, "Effects of a bisphosphonate on experimental periodontitis in monkeys", J Periodontol, 63, pp.825~830 (1992)
- Kinane DF, "Local antimicrobial therapies in periodontal disease", Ann R Australas Coll Dent Surg, 15, pp.57~60 (2000)
- Needleman IG, "The role of antibiotics in the treatment of periodontitis(Part 2--Controlled drug delivery)", Eur J Prosthodont Restor Dent, 3, pp.111~117 (1995)
- Yaffe A, "Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats", J Periodontol, 68, pp.884~889 (1997)
- Jeffcoat MK, "Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis", J Int Acad Periodontol, 9, pp.70~76 (2007)